Utility and Clinical Application of Circulating Tumor DNA (ctDNA) in Advanced Prostate Cancer
The treatment landscape for metastatic prostate cancer has undergone significant changes in recent years. The availability of next-generation imaging techniques and the emergence of novel therapies have led to earlier and more aggressive treatment approaches for patients. However, despite these adva...
Saved in:
| Main Authors: | Louise Kostos, Heidi Fettke, Edmond M. Kwan, Arun A. Azad |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-07-01
|
| Series: | Société Internationale d’Urologie Journal |
| Subjects: | |
| Online Access: | https://siuj.org/index.php/siuj/article/view/281/231 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of tumor‐informed and tumor‐naïve sequencing assays for ctDNA detection in breast cancer
by: Angela Santonja, et al.
Published: (2023-05-01) -
International society of liquid biopsy (ISLB) perspective on minimal requirements for ctDNA testing in solid tumors
by: Nicola Fusco, et al.
Published: (2025-06-01) -
The impact of ctDNA on metastatic cancer management: Current trends and future directions
by: Omveer Singh, et al.
Published: (2025-03-01) -
Longitudinal monitoring of disease burden and response using ctDNA from dried blood spots in xenograft models
by: Carolin M Sauer, et al.
Published: (2022-06-01) -
Cerebrospinal fluid Circulating Tumor DNA (ctDNA) as a biomarker for CNS metastases in Non-Small Cell Lung Cancer (NSCLC): a systematic review and meta-analysis comparing CSF ctDNA and traditional methods
by: Oluwatobi O. Olayode, et al.
Published: (2025-07-01)